Regulation of endothelial gene expression by cerebral cavernous malformation complex

脑海绵状血管瘤复合体对内皮基因表达的调节

基本信息

项目摘要

Project Summary/Abstract The Mentored Career Development Award will give me the opportunity to receive the additional training and research experience necessary to achieve my long-term goal of obtaining an independent faculty position at a research-oriented university, and contribute to the field of Cardiovascular Biology. The proposed project is a valuable tool to extent my knowledge and expertise in complex research methods, including mouse and zebrafish genetics/molecular biology, that are applied in the cardiovascular field. The University of California, San Diego (UCSD) School of Medicine conducts research in a multidisciplinary and highly collaborative environment by interacting with colleagues that span clinical medicine to structural and molecular biology. Moreover, the Ginsberg laboratory is well equipped with cellular, proteomic, and molecular biology tools to understand cellular and molecular biology of the protein products of genes implicated in cerebral cavernous malformations (CCM) (KRIT1, Krev- Interaction Trapped-1, CCM2, and PDCD10). In order to identify the major molecular processes involved in loss of Krit1-induced altered endothelial phenotype and function, a cell culture model to delete Krit1 in mouse endothelium in a time-controlled manner was established. To this end, transgenic mice bearing floxed alleles of Krit1 (Krit1fl/fl) and an endothelial-specific tamoxifen-regulated Cre recombinase (Pdgfb-iCreERT2) were used. In preliminary studies, an increase in expression of Kruppel-like factor 2 (KLF2), a transcription factor implicated in the effects of Krit1 on zebrafish heart development, and a decrease in expression of Thrombospondin 1(TSP1), an anti-angiogenic protein that antagonizes VEGF signaling, was observed. Gain-of-function experiments will be performed to assess whether re-expression of TSP1 can reverse loss of KRIT1 affects endothelial phenotype and function. Moreover, this will be extended by investigating whether TSP1 gene transcription is suppressed as a consequence of deletion of Krit1 in cultured cells. Since SP1/KLF binding sites in human and mouse TSP1 promoter region were identified, the role of KLF2 in downregulation of TSP1 in response to genetic inactivation of Krit1 will be investigated. In addition, the zebrafish CCM model will be used to assess the impact of loss of Tsp1 during cardiovascular malformations in vivo. The studies described in this proposal and the environment at UCSD will complete my training in complex research methods and provide insight into fundamental questions about the function of the KRIT1 gene at the endothelial cell and organism level.
项目总结/摘要 导师职业发展奖将使我有机会接受额外的培训 以及实现获得独立教师的长期目标所需的研究经验 在一所研究型大学的职位,并有助于心血管生物学领域。的 建议的项目是一个有价值的工具,以扩大我的知识和专业知识,在复杂的研究 方法,包括小鼠和斑马鱼遗传学/分子生物学,应用于 心血管领域加州大学圣地亚哥分校(UCSD)医学院 通过与同事互动,在多学科和高度协作的环境中进行研究, 从临床医学到结构和分子生物学。此外,金斯伯格实验室 配备了细胞,蛋白质组学和分子生物学工具,以了解细胞和分子 涉及脑海绵状畸形(CCM)的基因的蛋白产物的生物学(KRIT 1, Krev- Interaction Trapped-1、CCM 2和PDCD 10)。为了确定主要的分子过程 参与Krit 1诱导的内皮细胞表型和功能改变的损失, 以时间控制的方式在小鼠内皮中缺失Krit 1。为此,转基因 携带Krit 1 floxed等位基因(Krit 1fl/fl)和内皮特异性他莫昔芬调节Cre的小鼠 重组酶(Pdgfb-iCreERT 2)。在初步研究中, Kruppel样因子2(KLF 2),一种与Krit 1对斑马鱼心脏作用有关的转录因子 血栓反应蛋白1(TSP 1),一种抗血管生成蛋白, 拮抗VEGF信号传导。将进行功能增益实验, 评估TSP 1的再表达是否可以逆转KRIT 1的损失影响内皮表型, 功能此外,这将通过调查TSP 1基因转录是否是 在培养的细胞中由于Krit 1的缺失而被抑制。由于SP1/KLF结合位点在 人和小鼠TSP 1启动子区的鉴定,KLF 2在TSP 1下调中的作用, 对Krit 1基因失活的反应。此外,斑马鱼CCM模型 将用于评估体内心血管畸形期间Tsp 1丢失的影响。的 本建议中描述的研究和UCSD的环境将完成我在复杂的 研究方法,并提供有关KRIT 1基因功能的基本问题的见解 在内皮细胞和生物体水平。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Miguel Alejandro Lopez-Ramirez其他文献

Miguel Alejandro Lopez-Ramirez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Miguel Alejandro Lopez-Ramirez', 18)}}的其他基金

Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformations
缺氧导致脑海绵状血管瘤加重的机制
  • 批准号:
    10520059
  • 财政年份:
    2021
  • 资助金额:
    $ 18.07万
  • 项目类别:
Mechanisms of hypoxia induced exacerbation of cerebral cavernous malformations
缺氧导致脑海绵状血管瘤加重的机制
  • 批准号:
    10367164
  • 财政年份:
    2021
  • 资助金额:
    $ 18.07万
  • 项目类别:
Genetic and pharmacological manipulation of HEG1-KRIT1 protein complex modulates endothelial vasoprotective functions
HEG1-KRIT1 蛋白复合物的遗传和药理学操作调节内皮血管保护功能
  • 批准号:
    10676909
  • 财政年份:
    2020
  • 资助金额:
    $ 18.07万
  • 项目类别:
Genetic and pharmacological manipulation of HEG1-KRIT1 protein complex modulates endothelial vasoprotective functions
HEG1-KRIT1 蛋白复合物的遗传和药理学操作调节内皮血管保护功能
  • 批准号:
    10229372
  • 财政年份:
    2020
  • 资助金额:
    $ 18.07万
  • 项目类别:
Regulation of endothelial gene expression by cerebral cavernous malformation complex
脑海绵状血管瘤复合体对内皮基因表达的调节
  • 批准号:
    10198991
  • 财政年份:
    2018
  • 资助金额:
    $ 18.07万
  • 项目类别:
Regulation of endothelial gene expression by cerebral cavernous malformation complex
脑海绵状血管瘤复合体对内皮基因表达的调节
  • 批准号:
    9919443
  • 财政年份:
    2018
  • 资助金额:
    $ 18.07万
  • 项目类别:

相似国自然基金

由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
  • 批准号:
    82360313
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Nuclear force feedback as rheostat for actomyosin tension control
核力反馈作为肌动球蛋白张力控制的变阻器
  • 批准号:
    MR/Y001125/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Research Grant
CAREER: Cytokinesis without an actomyosin ring and its coordination with organelle division
职业:没有肌动球蛋白环的细胞分裂及其与细胞器分裂的协调
  • 批准号:
    2337141
  • 财政年份:
    2024
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Continuing Grant
CAREER: Computational and Theoretical Investigation of Actomyosin Contraction Systems
职业:肌动球蛋白收缩系统的计算和理论研究
  • 批准号:
    2340865
  • 财政年份:
    2024
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Continuing Grant
Elucidation of the mechanism by which actomyosin emerges cell chirality
阐明肌动球蛋白出现细胞手性的机制
  • 批准号:
    23K14186
  • 财政年份:
    2023
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Deciphering actomyosin contractility regulation during incomplete germ cell division
破译不完全生殖细胞分裂过程中肌动球蛋白收缩性的调节
  • 批准号:
    573067-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 18.07万
  • 项目类别:
    University Undergraduate Student Research Awards
CAREER: Actuating robots with actomyosin active gels
职业:用肌动球蛋白活性凝胶驱动机器人
  • 批准号:
    2144380
  • 财政年份:
    2022
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Continuing Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201236
  • 财政年份:
    2022
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Standard Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201235
  • 财政年份:
    2022
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Standard Grant
Coordination of actomyosin and anillo-septin sub-networks of the contractile ring during cytokinesis
胞质分裂过程中收缩环肌动球蛋白和 anillo-septin 子网络的协调
  • 批准号:
    463633
  • 财政年份:
    2022
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Operating Grants
The integrin-dependent B cell actomyosin network drives immune synapse formation and B cell functions
整合素依赖性 B 细胞肌动球蛋白网络驱动免疫突触形成和 B 细胞功能
  • 批准号:
    546047-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 18.07万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了